Steward Partners Investment Advisory’s Ascendis Pharma A/S ASND Stock Holding History

Steward Partners Investment Advisory’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7	Closed	-$1.6K	–	4668
2026 Q1	$1.6K	Hold	7	–	–	﹤0.01%	4110
2025 Q4	$1.49K	Hold	7	–	–	﹤0.01%	4018
2025 Q3	$1.39K	Hold	7	–	–	﹤0.01%	3999
2025 Q2	$1.21K	Buy	+7	New	+$1.14K	﹤0.01%	3828
2021 Q1	–	Sell	-20	Closed	-$3K	–	3413
2020 Q4	$3K	Hold	20	–	–	﹤0.01%	2611
2020 Q3	$3K	Hold	20	–	–	﹤0.01%	2473
2020 Q2	$3K	Hold	20	–	–	﹤0.01%	2367
2020 Q1	$2K	Sell	20 -10	-33%	-$1.3K	﹤0.01%	2260
2019 Q4	$4K	Buy	30 +10	+50%	+$1.11K	﹤0.01%	2280
2019 Q3	$1K	Buy	+20	New	+$2.23K	﹤0.01%	2492

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Steward Partners Investment Advisory's ASND Position: Q2 2026 in Review

Steward Partners Investment Advisory sold out of Ascendis Pharma A/S (ASND) in Q2 2026, closing a stake of 7 shares — an estimated $1.6K sold.

Steward Partners Investment Advisory first reported a position in ASND in Q3 2019 and held it in 10 quarters. The position peaked at $4K in Q4 2019. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Steward Partners Investment Advisory reported no remaining Ascendis Pharma A/S position as of Q2 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 7 Ascendis Pharma A/S shares in Q2 2026, an estimated $1.6K.
Steward Partners Investment Advisory first reported a position in Ascendis Pharma A/S in Q3 2019 and held it in 10 quarters.
Steward Partners Investment Advisory's Ascendis Pharma A/S position peaked at $4K in Q4 2019.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.